Literature DB >> 6609077

The effect of alcoholic cirrhosis on the two kinetic components (high and low affinity) of the microsomal 0-deethylation of 7-ethoxycoumarin in human liver.

K W Woodhouse, F M Williams, E Mutch, P Wright, O F James, M D Rawlins.   

Abstract

The activities of the two kinetic components (high and low affinity) of the microsomal 0-deethylation of 7-ethoxycoumarin have been measured in liver from patients with alcoholic cirrhosis and in normals. The activity (expressed as pmol 7-OH coumarin formed/mg microsomal protein/min) of both components of the enzyme was significantly lower in alcoholic cirrhosis (high affinity = 3.27 +/- 1.18, low affinity 60.9 +/- 11.6) than in normals (high affinity 9.43 +/- 2.37, low affinity 111.3 +/- 9.2). These results are further evidence that there is a broad impairment of hepatic microsomal mono-oxygenase activity in alcoholic cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6609077     DOI: 10.1007/bf00546710

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  7 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Biphasic O-deethylation of phenacetin and 7-ethoxycoumarin by human and rat liver microsomal fractions.

Authors:  A R Boobis; G C Kahn; C Whyte; M J Brodie; D S Davies
Journal:  Biochem Pharmacol       Date:  1981-09-01       Impact factor: 5.858

3.  Aldrin epoxidation kinetics in small samples of human liver.

Authors:  F M Williams; K W Woodhouse; D Middleton; P Wright; O James; M D Rawlins
Journal:  Biochem Pharmacol       Date:  1982-11-15       Impact factor: 5.858

4.  An improved assay of 7-ethoxycoumarin O-deethylase activity: induction of hepatic enzyme activity in C57BL/6J and DBA/2J mice by phenobarbital, 3-methylcholanthrene and 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  W F Greenlee; A Poland
Journal:  J Pharmacol Exp Ther       Date:  1978-06       Impact factor: 4.030

5.  Drug metabolism in liver disease: activity of hepatic microsomal metabolizing enzymes.

Authors:  G C Farrell; W G Cooksley; L W Powell
Journal:  Clin Pharmacol Ther       Date:  1979-10       Impact factor: 6.875

6.  The effect of alcoholic cirrhosis on the activities of microsomal aldrin epoxidase, 7-ethoxycoumarin O-de-ethylase and epoxide hydrolase, and on the concentrations of reduced glutathione in human liver.

Authors:  K W Woodhouse; F M Williams; E Mutch; P Wright; O F James; M D Rawlins
Journal:  Br J Clin Pharmacol       Date:  1983-06       Impact factor: 4.335

7.  Influence of liver disease and environmental factors on hepatic monooxygenase activity in vitro.

Authors:  M J Brodie; A R Boobis; C J Bulpitt; D S Davies
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

  7 in total
  8 in total

1.  Comparison of in vitro and in vivo biotransformation in patients with liver disease of differing severity.

Authors:  H Kraul; J Truckenbrodt; A Huster; R Töpfer; A Hoffmann
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 2.  The pharmacokinetics of non-steroidal anti-inflammatory drugs in the elderly.

Authors:  K W Woodhouse; H Wynne
Journal:  Clin Pharmacokinet       Date:  1987-02       Impact factor: 6.447

3.  Conjugation pathways in liver disease.

Authors:  G M Pacifici; A Viani; M Franchi; S Santerini; A Temellini; L Giuliani; M Carrai
Journal:  Br J Clin Pharmacol       Date:  1990-09       Impact factor: 4.335

4.  7-Ethoxyresorufin deethylase (EROD) in human liver--the effect of alcoholic liver disease.

Authors:  K W Woodhouse; E Mutch; F M Williams; O F James; M D Rawlins
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 5.  The problems and pitfalls of NSAID therapy in the elderly (Part II).

Authors:  A G Johnson; R O Day
Journal:  Drugs Aging       Date:  1991-05       Impact factor: 3.923

6.  Inhibition of human liver cytochrome P-450 by omeprazole.

Authors:  J C Jensen; R Gugler
Journal:  Br J Clin Pharmacol       Date:  1986-03       Impact factor: 4.335

7.  The metabolism of 7-ethoxycoumarin in human liver microsomes and the effect of primary biliary cirrhosis: implications for studies of drug metabolism in liver disease.

Authors:  K W Woodhouse; H C Mitchison; E Mutch; P D Wright; M D Rawlins; O F James
Journal:  Br J Clin Pharmacol       Date:  1985-07       Impact factor: 4.335

8.  Isolation of human hepatic microsomes and their inhibition by cimetidine and ranitidine.

Authors:  H P Hoensch; H Hutzel; W Kirch; E E Ohnhaus
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.